Stock Earnings

Question 1

What are Pharming Group NV's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Pharming Group NV has a total asset of $400, Net loss of $-12

Question 2

What are the key financial ratios for PHAR?

Accepted Answer

Pharming Group NV's Current ratio is 2.23, has a Net margin is -4.04, sales per share of $0.44.

Question 3

How is Pharming Group NV's revenue broken down by segment or geography?

Accepted Answer

Pharming Group NV largest revenue segment is Recombinant Human C1 Esterase Inhibitor, at a revenue of 226,910,050 in the most earnings release.For geography, United States is the primary market for Pharming Group NV, at a revenue of 221,166,908.

Question 4

Is Pharming Group NV profitable?

Accepted Answer

no, according to the latest financial statements, Pharming Group NV has a net loss of $-12

Question 5

Does Pharming Group NV have any liabilities?

Accepted Answer

yes, Pharming Group NV has liability of 179

Question 6

How many outstanding shares for Pharming Group NV?

Accepted Answer

Pharming Group NV has a total outstanding shares of 680

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	362	297	245	205	198	212
Revenue Growth (YoY)	27%	21%	20%	4%	-7%	18%
Cost of Revenue	36	35	25	17	21	23
Gross Profit	325	261	220	188	177	188
Selling, General & Admin	204	175	166	120	85	70
Research & Development	88	81	66	50	62	35
Operating Expenses	288	265	242	177	153	112
Other Non Operating Income (Expenses)	--	-1	--	--	0	-3
Pretax Income	14	-8	-12	14	23	44
Income Tax Expense	14	3	-1	1	7	6
Net Income	0	-12	-11	13	15	37
Net Income Growth	-100%	9%	-185%	-13%	-59%	-3%
Shares Outstanding (Diluted)	502	671	657	707.14	701.15	682.73
Shares Change (YoY)	-3%	2%	-7%	1%	3%	1%
EPS (Diluted)	0.01	-0.02	-0.02	0.01	0.02	0.05
EPS Growth	-138%	0%	-204%	-15%	-59%	-3%
Free Cash Flow	52	-2	-18	20	21	68
Free Cash Flow Per Share	0.1	0	-0.02	0.02	0.02	0.09
Gross Margin	89.77%	87.87%	89.79%	91.7%	89.39%	88.67%
Operating Margin	9.94%	-1.01%	-8.57%	4.87%	12.12%	35.84%
Profit Margin	0%	-4.04%	-4.48%	6.34%	7.57%	17.45%
Free Cash Flow Margin	14.36%	-0.67%	-7.34%	9.75%	10.6%	32.07%
EBITDA	51	13	-5	23	43	84
EBITDA Margin	14.08%	4.37%	-2.04%	11.21%	21.71%	39.62%
D&A For EBITDA	15	16	16	13	19	8
EBIT	36	-3	-21	10	24	76
EBIT Margin	9.94%	-1.01%	-8.57%	4.87%	12.12%	35.84%
Effective Tax Rate	100%	-37.5%	8.33%	7.14%	30.43%	13.63%

Pharming Group NV (PHAR) Price

PHAR Stock Price Chart

PHAR Income

Follow-Up Questions